Regenxbio Inc

Healthcare · Biotechnology

8.10$ +6.5% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Regenxbio Inc (RGNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 387 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RGNX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	196	173	224	224	209	199	317	336	515	544	519	529	509	498	464	450	541	708	879	836	800	1,114	1,025	953	884	833	748	682	634	574	629	569	519	466	491	581	525	453	342	387
Current Assets	97	93	149	166	172	168	263	293	386	338	304	359	360	345	338	329	387	531	499	437	410	519	447	465	437	416	389	379	366	335	395	347	313	278	313	374	332	281	187	236
Cash	28	25	82	58	60	47	72	107	142	76	56	55	80	70	69	94	93	338	291	257	228	345	192	121	119	97	70	69	53	35	113	58	57	58	130	80	59	34	15	36
Cash & Short-Term Investments	92	90	146	162	167	161	230	286	373	320	285	341	332	296	279	269	242	476	441	375	340	457	394	403	382	365	332	320	302	275	339	290	255	235	268	323	274	230	150	106
Receivables	0.7	1.0	0.2	0.1	0.9	0.5	26	0.7	2.6	8.6	8.4	9.7	19	38	45	43	122	43	41	44	46	32	27	38	33	30	23	27	32	26	17	24	25	22	19	21	26	27	11	107
Inventory	2.2	1.8	1.8	2.4	3.2	5.3	4.7	3.7	6.3	5.7	6.3	6.0	6.9	6.5	7.4	9.7	16	11	14	13	18	19	19	0.0	15	14	16	15	13	–	0.0	–	-13	–	–	–	–	–	–	–
Property, Plant & Equipment	5.8	9.3	11	12	12	14	15	17	20	29	30	33	34	39	40	41	39	56	89	169	184	192	135	139	141	207	142	–	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	16	11	11	13	15	16	18	19	21	35	32	35	41	48	44	52	126	330	325	329	339	350	336	323	320	317	283	277	271	262	239	221	218	206	217	367	364	350	321	315
Current Liabilities	14	9.7	10.0	11	13	14	15	17	19	22	21	25	31	34	32	40	64	81	84	92	107	130	120	115	124	130	112	118	127	130	110	98	103	103	107	120	125	118	71	83
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	2.4	2.3	2.5	2.4	2.5	3.0	3.6	2.5	1.8	1.7	1.3	1.8	2.1	2.8	3.6	6.0	6.3	6.3	6.6	7.1	46	39	7.7	7.9	7.9	8.0	51	48	7.9	7.4
Accounts Payable	5.4	1.5	4.1	3.9	2.6	4.8	5.0	4.2	5.2	4.4	4.2	5.9	9.6	6.4	9.0	11	15	11	11	9.4	20	11	25	17	25	27	23	12	22	23	31	16	20	23	19	22	22	21	21	16
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	5.5	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	180	162	213	212	195	183	299	317	494	509	487	495	468	450	420	398	416	378	555	507	461	764	690	631	564	516	465	406	363	312	391	348	301	260	274	214	161	103	21	72
Retained Earnings	-95	-115	-137	-151	-172	-188	-79	-68	-87	-83	-115	-117	-151	-178	-218	-252	-243	-289	-339	-397	-455	-161	-238	-306	-382	-442	-508	-580	-642	-705	-768	-821	-881	-932	-926	-997	-1,059	-1,126	-1,216	-1,193
Shares Outstanding	26	26	27	31	31	31	34	35	34	39	36	37	37	37	37	37	39	37	42	43	43	44	43	43	43	43	43	44	44	44	46	51	51	51	51	51	52	52	52	53

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings